Dominik Obrist

Title: The Innovations of Dominik Obrist in Microfluidic Technology

Introduction

Dominik Obrist, an accomplished inventor based in Suhr, Switzerland, has made significant contributions to the field of medical technology with a focus on microfluidic systems. With one patent to his name, Obrist's work aims to enhance the understanding and treatment of microvascular obstruction (MVO) in patients, showcasing the importance of innovative solutions in healthcare.

Latest Patents

Dominik Obrist's patent, titled "Microfluidic Coronary Circulatory Model," introduces systems, methods, and apparatus that are specifically designed to model MVO in patients. This multi-scale model mimics myocardial microcirculation in coronary vessels, incorporating collaterals that provide alternative pathways potentially bypassing the MVO. It also models coronary artery compliance, facilitating spatially resolved fluid transport through these vessels. The model can simulate MVO by increasing flow resistance or blocking vessels entirely, and it is adept at mimicking fluid transport behaviors during diagnostic or treatment phases. This innovation aims to optimize therapy protocols for conditions related to MVO, marking a significant advancement in medical modeling.

Career Highlights

Dominik Obrist is currently associated with Corflow Therapeutics AG, where his expertise in microfluidic technology plays a pivotal role in the company's mission to improve patient outcomes. His research and development efforts focus on creating novel solutions that address complex medical challenges, reflecting the urgent need for innovation in therapeutic protocols related to microcirculation.

Collaborations

Throughout his career, Obrist has collaborated with fellow researchers and colleagues such as Andre Bernard and Peter Heeb. These collaborations highlight the importance of teamwork in driving forward innovations and refining medical technologies. Together, they work towards enhancing the understanding and treatment of coronary health issues, demonstrating a collective effort in advancing medical science.

Conclusion

Dominik Obrist's commitment to innovation in microfluidic technology underscores the vital role inventors play in shaping the future of healthcare. His patented microfluidic coronary circulatory model stands as a testament to the potential of engineering solutions to solve complex medical problems. As he continues to work at Corflow Therapeutics AG alongside distinguished colleagues, the impact of his contributions will likely resonate throughout the field, benefiting patients and healthcare professionals alike.